mouse anti vsv m Search Results


mouse anti-vsv-m [clone 23h12, kerafast, boston, ma, usa]  (Absolute Biotech)
90
Absolute Biotech mouse anti-vsv-m [clone 23h12, kerafast, boston, ma, usa]
Mouse Anti Vsv M [Clone 23h12, Kerafast, Boston, Ma, Usa], supplied by Absolute Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-vsv-m [clone 23h12, kerafast, boston, ma, usa]/product/Absolute Biotech
Average 90 stars, based on 1 article reviews
mouse anti-vsv-m [clone 23h12, kerafast, boston, ma, usa] - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
anti vsv m monoclonal antibody 23h12  (ProSci Incorporated)
93
ProSci Incorporated anti vsv m monoclonal antibody 23h12
Anti Vsv M Monoclonal Antibody 23h12, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti vsv m monoclonal antibody 23h12/product/ProSci Incorporated
Average 93 stars, based on 1 article reviews
anti vsv m monoclonal antibody 23h12 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
mouse anti vsv m  (Absolute Biotech Inc)
86
Absolute Biotech Inc mouse anti vsv m
Mouse Anti Vsv M, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti vsv m/product/Absolute Biotech Inc
Average 86 stars, based on 1 article reviews
mouse anti vsv m - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
goat igg anti-mouse igg (h + l)-hrpo  (Biozol Diagnostica Vertrieb GmbH)
90
Biozol Diagnostica Vertrieb GmbH goat igg anti-mouse igg (h + l)-hrpo
A Efficiency of ACE2 binding. Left: 293T cells transiently expressing the indicated S proteins (or no S protein) were incubated with the indicated concentrations of soluble ACE2 harboring a C-terminal Fc-tag (derived from human <t>immunoglobulin</t> <t>G;</t> solACE2-Fc) and then incubated with an AlexaFluor-488-coupled secondary antibody. Subsequently, ACE2 binding was analyzed by flow cytometry and normalized against the assay background (signals for samples without soluble ACE2, set as 1). Right: Area under the curve (AUC) data for ACE2 binding. Both panels show average (mean) data ± SEM from three biological replicates (each with single samples). Please also see Supplementary Fig. . B Impact of ACE2 blockade on S protein-driven cell entry. Left: Vero cells were preincubated with different concentrations of anti-ACE2 antibody and subsequently inoculated with pseudoviruses bearing the indicated S proteins or <t>VSV-G</t> (or no S protein). Cell entry was assessed by measuring the activity of pseudovirus-encoded firefly luciferase in cell lysates at 16–18 h after inoculation and normalized against samples that were not exposed to anti-ACE2 antibody (set as 0% inhibition). Right: AUC data for ACE2 blockade. Both panels show average (mean) data ± SEM from three biological replicates (each with four technical replicates). C Cell entry mediated by S proteins. Cell entry was assessed by measuring the activity of pseudovirus-encoded firefly luciferase in cell lysates at 16–18 h after inoculation of cells with particles containing the indicated S proteins (or no S protein). The average (mean) data ± SEM from 6 to 12 biological replicates (each with four technical replicates) are presented, with entry standardized against B.1 (set as 1). Please also see Supplementary Fig. . For all panels statistical significance was analyzed by two-tailed Student’s t -tests with Welch correction ( p > 0.05, not significant [ns]; p ≤ 0.05, *; p ≤ 0.01, **; p ≤ 0.001, ***), see also Extended Data Table . AUC area under the curve.
Goat Igg Anti Mouse Igg (H + L) Hrpo, supplied by Biozol Diagnostica Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat igg anti-mouse igg (h + l)-hrpo/product/Biozol Diagnostica Vertrieb GmbH
Average 90 stars, based on 1 article reviews
goat igg anti-mouse igg (h + l)-hrpo - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
primary antibodies  (Santa Cruz Biotechnology)
95
Santa Cruz Biotechnology primary antibodies
A Efficiency of ACE2 binding. Left: 293T cells transiently expressing the indicated S proteins (or no S protein) were incubated with the indicated concentrations of soluble ACE2 harboring a C-terminal Fc-tag (derived from human <t>immunoglobulin</t> <t>G;</t> solACE2-Fc) and then incubated with an AlexaFluor-488-coupled secondary antibody. Subsequently, ACE2 binding was analyzed by flow cytometry and normalized against the assay background (signals for samples without soluble ACE2, set as 1). Right: Area under the curve (AUC) data for ACE2 binding. Both panels show average (mean) data ± SEM from three biological replicates (each with single samples). Please also see Supplementary Fig. . B Impact of ACE2 blockade on S protein-driven cell entry. Left: Vero cells were preincubated with different concentrations of anti-ACE2 antibody and subsequently inoculated with pseudoviruses bearing the indicated S proteins or <t>VSV-G</t> (or no S protein). Cell entry was assessed by measuring the activity of pseudovirus-encoded firefly luciferase in cell lysates at 16–18 h after inoculation and normalized against samples that were not exposed to anti-ACE2 antibody (set as 0% inhibition). Right: AUC data for ACE2 blockade. Both panels show average (mean) data ± SEM from three biological replicates (each with four technical replicates). C Cell entry mediated by S proteins. Cell entry was assessed by measuring the activity of pseudovirus-encoded firefly luciferase in cell lysates at 16–18 h after inoculation of cells with particles containing the indicated S proteins (or no S protein). The average (mean) data ± SEM from 6 to 12 biological replicates (each with four technical replicates) are presented, with entry standardized against B.1 (set as 1). Please also see Supplementary Fig. . For all panels statistical significance was analyzed by two-tailed Student’s t -tests with Welch correction ( p > 0.05, not significant [ns]; p ≤ 0.05, *; p ≤ 0.01, **; p ≤ 0.001, ***), see also Extended Data Table . AUC area under the curve.
Primary Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
primary antibodies - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
anti-vsv-m  (Absolute Antibody Ltd)
N/A
This is a recombinant monoclonal antibody.
   Buy from Supplier

Image Search Results


A Efficiency of ACE2 binding. Left: 293T cells transiently expressing the indicated S proteins (or no S protein) were incubated with the indicated concentrations of soluble ACE2 harboring a C-terminal Fc-tag (derived from human immunoglobulin G; solACE2-Fc) and then incubated with an AlexaFluor-488-coupled secondary antibody. Subsequently, ACE2 binding was analyzed by flow cytometry and normalized against the assay background (signals for samples without soluble ACE2, set as 1). Right: Area under the curve (AUC) data for ACE2 binding. Both panels show average (mean) data ± SEM from three biological replicates (each with single samples). Please also see Supplementary Fig. . B Impact of ACE2 blockade on S protein-driven cell entry. Left: Vero cells were preincubated with different concentrations of anti-ACE2 antibody and subsequently inoculated with pseudoviruses bearing the indicated S proteins or VSV-G (or no S protein). Cell entry was assessed by measuring the activity of pseudovirus-encoded firefly luciferase in cell lysates at 16–18 h after inoculation and normalized against samples that were not exposed to anti-ACE2 antibody (set as 0% inhibition). Right: AUC data for ACE2 blockade. Both panels show average (mean) data ± SEM from three biological replicates (each with four technical replicates). C Cell entry mediated by S proteins. Cell entry was assessed by measuring the activity of pseudovirus-encoded firefly luciferase in cell lysates at 16–18 h after inoculation of cells with particles containing the indicated S proteins (or no S protein). The average (mean) data ± SEM from 6 to 12 biological replicates (each with four technical replicates) are presented, with entry standardized against B.1 (set as 1). Please also see Supplementary Fig. . For all panels statistical significance was analyzed by two-tailed Student’s t -tests with Welch correction ( p > 0.05, not significant [ns]; p ≤ 0.05, *; p ≤ 0.01, **; p ≤ 0.001, ***), see also Extended Data Table . AUC area under the curve.

Journal: Nature Communications

Article Title: Omicron subvariant BA.5 efficiently infects lung cells

doi: 10.1038/s41467-023-39147-4

Figure Lengend Snippet: A Efficiency of ACE2 binding. Left: 293T cells transiently expressing the indicated S proteins (or no S protein) were incubated with the indicated concentrations of soluble ACE2 harboring a C-terminal Fc-tag (derived from human immunoglobulin G; solACE2-Fc) and then incubated with an AlexaFluor-488-coupled secondary antibody. Subsequently, ACE2 binding was analyzed by flow cytometry and normalized against the assay background (signals for samples without soluble ACE2, set as 1). Right: Area under the curve (AUC) data for ACE2 binding. Both panels show average (mean) data ± SEM from three biological replicates (each with single samples). Please also see Supplementary Fig. . B Impact of ACE2 blockade on S protein-driven cell entry. Left: Vero cells were preincubated with different concentrations of anti-ACE2 antibody and subsequently inoculated with pseudoviruses bearing the indicated S proteins or VSV-G (or no S protein). Cell entry was assessed by measuring the activity of pseudovirus-encoded firefly luciferase in cell lysates at 16–18 h after inoculation and normalized against samples that were not exposed to anti-ACE2 antibody (set as 0% inhibition). Right: AUC data for ACE2 blockade. Both panels show average (mean) data ± SEM from three biological replicates (each with four technical replicates). C Cell entry mediated by S proteins. Cell entry was assessed by measuring the activity of pseudovirus-encoded firefly luciferase in cell lysates at 16–18 h after inoculation of cells with particles containing the indicated S proteins (or no S protein). The average (mean) data ± SEM from 6 to 12 biological replicates (each with four technical replicates) are presented, with entry standardized against B.1 (set as 1). Please also see Supplementary Fig. . For all panels statistical significance was analyzed by two-tailed Student’s t -tests with Welch correction ( p > 0.05, not significant [ns]; p ≤ 0.05, *; p ≤ 0.01, **; p ≤ 0.001, ***), see also Extended Data Table . AUC area under the curve.

Article Snippet: Membranes were then treated with anti-rabbit (S2, goat IgG anti-rabbit IgG (H + L)-HRPO (Dianova, Cat: 111-035-003)) or anti-mouse (VSV-M, goat IgG anti-mouse IgG (H + L)-HRPO (Dianova, Cat: 115-035-003)) secondary antibodies coupled with horseradish peroxidase (1:2000).

Techniques: Binding Assay, Expressing, Incubation, Derivative Assay, Flow Cytometry, Activity Assay, Luciferase, Inhibition, Two Tailed Test